New research has revealed a potential drug target for chikungunya related arthritis. Professor Andreas Suhrbier, head of the Inflammation Biology Laboratory at QIMR Berghofer, told the limbic it was previously thought an interferon response drove the inflammation seen in chikungunya arthritis. However his research team has found the protease granzyme A is the major player ...
Enzyme a potential target in chikungunya arthritis
By Mardi Chapman
20 Feb 2017